Peer Review reports
From: Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
| Original Submission | ||
|---|---|---|
| 3 Apr 2021 | Submitted | Original manuscript |
| 15 Apr 2021 | Reviewed | Reviewer Report |
| 18 Apr 2021 | Reviewed | Reviewer Report |
| 28 Apr 2021 | Reviewed | Reviewer Report |
| 6 May 2021 | Author responded | Author comments - Minshan Chen |
| Resubmission - Version 2 | ||
| 6 May 2021 | Submitted | Manuscript version 2 |
| 6 May 2021 | Author responded | Author comments - Minshan Chen |
| Resubmission - Version 3 | ||
| 6 May 2021 | Submitted | Manuscript version 3 |
| 7 May 2021 | Author responded | Author comments - Minshan Chen |
| Resubmission - Version 4 | ||
| 7 May 2021 | Submitted | Manuscript version 4 |
| 8 May 2021 | Reviewed | Reviewer Report |
| 9 May 2021 | Reviewed | Reviewer Report |
| 23 May 2021 | Reviewed | Reviewer Report |
| 25 May 2021 | Author responded | Author comments - Minshan Chen |
| Resubmission - Version 5 | ||
| 25 May 2021 | Submitted | Manuscript version 5 |
| 27 May 2021 | Reviewed | Reviewer Report |
| 27 May 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 27 May 2021 | Editorially accepted | |
| 4 Jul 2021 | Article published | 10.1186/s12885-021-08428-w |
You can find further information about peer review here.